Consultant, Drug Safety Counts LLC
Susan has been active industry-wide in topics relating to quantifying patient safety since 2011 when she joined GSK's pharmacovigilance department's benefit-risk initiative. She is currently co-lead of a cross-functional initiative on safety monitoring. She has authored several publications...
Read More →